Evaluation of the Impact of a Patient Education Protocol on the Quality of 18F-FDG PET Imaging Indicated for Investigation of Cardiac Inflammation
Key facts
- Where
- Paris, FranceSee the 2 sites
Where in France
- Hôpital Cochin - AP-HP, Service de médecine nucléaireParis, FranceContact: Olivier CASASSUS-BUILHENo longer taking part
- Hôpital Européen Georges Pompidou - AP-HP, Service de médecine nucléaireParis, FranceContact: Julien HONo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Trial code
- NCT07029295
- Record updated
- 19 June 2025
- Original description
The aim of this study is to assess the impact of implementing a patient education and preparation protocol for FDG PET (18F-FDG PET) imaging on the quality of imaging results.Read full original descriptionShow less
The aim of this study is to assess the impact of implementing a patient education and preparation protocol for FDG PET (18F-FDG PET) imaging on the quality of imaging results.
18F-FDG (18Fluor-FluoroDesoxyGlucose) PET (Positron Emission Tomography) is indicated for the diagnosis of cardiac inflammation. To detect cardiac inflammation, the myocardium (heart muscle) must be prevented from absorbing glucose from the diet (FDG). To achieve this, patient preparation is essential. Poor preparation can compromise the interpretation of results, causing diagnostic delay.
To answer the research question, the investigators plan to include 138 people with suspected infective endocarditis or cardiac sarcoidosis, in two institutions of the Assistance Publique - Hôpitaux de Paris: Hôpital Européen Georges Pompidou and Hôpital Cochin-Port-Royal, located respectively at 20 rue Leblanc 75015 Paris and 27 rue du Faubourg Saint-Jacques 75014 Paris.
Inclusion: Presence of a prescription validated by the nuclear medicine department for an 18F-FDG PET scan for the detection of inflammation of cardiac inflammation or infection; Age greater than or equal to 18; Membership of a social security scheme or equivalent; Patients with an e-mail address; Patients who understand French; Collection of patient consent.
Exclusion: Pregnancy or breast-feeding; Patients (inpatients or outpatients) already on a diet (including ketogenic); Patients who do not understand protocol; Patients deprived of liberty by judicial or administrative decision; Patients under legal protection (guardianship/trusteeship); Patients under court protection.